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Introduction: Adenoidectomy is one of the most frequent surgeries conducted
in children along with tonsillectomy. The persistence of nasal obstruction and
recurrent infection symptoms following adenoidectomy was reported in the
range of 19–26% in the literature. In a recent survey of otolaryngologists in the
United Kingdom, 38.8% recognized that the need for revision adenoidectomy is a
problem. This study aims at evaluation of the value of using intranasal steroids to
prevent recurrence of adenoid and related symptoms after adenoidectomy. This
is to judge whether the use of intranasal steroids may obtain successful results in
children to avoid surgery for adenoid recurrence.
Material and Methods: Sixty children after adenoidectomy were divided
randomly into 2 groups. Group I received postoperative intranasal steroid and
group II received postoperative intranasal saline spray. Both medications were
administered for 8 weeks postoperatively. Patients were followed up for 6
months using the nasopharyngeal lateral X-rays and reporting the degree of the
symptoms. Results: The intranasal steroid group recurrence as evident by lateral
X-ray nasopharynx was found in 1 case (3.3%) and for intranasal saline group
recurrence was found in 7 cases (23.3%) (P-value= 0.05). The intranasal steroid
group had significantly lower score after 6 months as regards nasal obstruction,
nasal discharge, snoring, nasal tone and recurrent infection than the intranasal
saline group. Conclusion: This study has demonstrated that the use of steroid
nasal spray following adenoidectomy significantly reduces the rate of adenoid
regrowth and the recurrence of nasal symp.
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Introduction
ADENOIDECTOMY is one of the most common surgical
procedures performed in children. The adenoid tissue is part
of the Waldeyer’s ring and is located at the nasopharynx. It is
the most frequent cause of upper respiratory tract obstruction
among children. The most frequent symptoms of adenoid
hyperplasia are snoring, mouth breathing, nasal discharge,
sleep apnea and hyponasal speech. [1] Hyperplastic
adenoid tissue may also be a source of recurrent infection.
[2] Adenoidectomy performed for the above-mentioned
indications is one of the most frequent surgeries conducted
in children along with tonsillectomy. [3]
The persistence of nasal obstruction and recurrent infection
symptoms following adenoidectomy was reported in the
range of 19–26% in a study. [4]
Over the past few years, adenoid re-growth after
adenoidectomy has received much attention. Previously
published studies suggested that the rate of this phenomenon
varied between 0.55% [5] and 1.6%. [6]
In a recent survey of otolaryngologists in the United Kingdom,
38.8% recognized that the need for revision adenoidectomy
is a problem. [7]
While it is a well-recognized entity, uncertainty remains
regarding its risk factors. Adenoid regrowth may be
attributable to surgery that is performed under indirect view.
Also, the lymphoid tissue does not have a clear delineation.
There are 2 difficulties that have been described to prevent
complete adenoidal removal. Firstly, lymphoid tissue in the
pharyngeal recess is considered by all authors as difficult to
remove. [8] The second difficulty is the bulging adenoidal
tissue into the posterior choanae, which was addressed by

Pearl and Manoukian; [9] they found choanal adenoids in 9%
of their study group.
Other hypotheses on what causes the recurrence of adenoid
obstructive symptoms include the contribution of other
pathologic conditions such as allergies, gastroesophageal
reflux disease, [10] an unrecognized intranasal pathologic
condition, [11] or tubal tonsil hyperplasia. [12] In addition,
young age may lead to an increased rate of repeated
adenoidectomy through a mechanism that remains uncertain.
[13]
There are several studies suggesting the use of intranasal
corticosteroids for children with adenoid vegetation as
an alternative to surgery. [14] However, a limited number
of studies have been performed to prevent regrowth after
adenoidectomy. [15]
Aim of the work
The study aims at evaluation of the value of using intranasal
steroids to prevent recurrence of adenoid and related
symptoms after adenoidectomy. This is to judge whether the
use of intranasal steroids may obtain successful results in
children to avoid surgery for adenoid recurrence.
Our concern was not to evaluate the most appropriate drug,
the most efficient dose, and optimal treatment duration. It is
merely to evaluate the value of the use of intranasal steroids
after adenoidectomy and its effect on the recurrence rate of
adenoid regrowth and symptom scores.
Material and Methods
This study included 60 patients, of both genders, all suffering
from hypertrophied adenoid tissue, presented clinically with
mouth breathing, snoring, bilateral nasal obstruction and/or
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discharge and evidenced radiologically with plain x-ray film
lateral view to the nasopharynx. All cases presented to the
outpatient clinic of the otolaryngology department, during
the period from June 2016 through January 2017, seeking
for management of their problem. Adenoidectomy for all
patients was performed by the same surgeon. Patients after
adenoidectomy were divided into 2 groups. Randomization
was done with every other patient consecutively. Group I
received postoperative intranasal steroid fluticasone furoate
(27.5 mcg/day) and group II received intranasal saline spray
starting at postoperative week 2 after wound healing. Both
medications were administered for 8 weeks postoperatively.
Patients were followed up for 6 months. Follow up was
done using the nasopharyngeal lateral X-rays and reporting
the degree of the symptoms. All patients or parents were
asked to report the degree of the symptoms after 2 weeks,
6 months.
Inclusion criteria were:
1. Patients’ age ranged between 3 years to 12 years.
2. Adenoid is the only cause for nasal obstruction.
3. History of mouth breathing, snoring, bilateral nasal
obstruction and/or bilateral nasal discharge.
4. X-ray evidence of adenoid hypertrophy encroaching on
the airway column.
Exclusion criteria were:
1. Patients younger than 3 years and older than 12 years
old.
2. Recurrent cases.
3. The use of intranasal or systemic steroids within the last
1 year.
4. Use of any intranasal medication within the previous 2
weeks of entering the study.
5. Acute URTI within 2 weeks of entering the study.
6. History of epistaxis.
7. Immunodeficiency disorders.
8. Hypersensitivity to the fluticasone furoate.
9. History of craniofacial neuromuscular or genetic disorder.
Procedure:
All patients were subjected to the following protocol:
A. Preoperative preparation: in the form of Careful history
taking from the parents, general and local clinical
examination, investigations and detailed consent from
the parents.
B.

Operative technique: All patients were operated under
general anesthesia with oral endotracheal intubation, a
Davis-Bowel mouth gag was used to open the mouth.
The nasopharynx was palpated digitally to examine for
adenoid hypertrophy. Using the conventional curette, the
hypertrophied adenoid tissue was removed. Endoscopic
evaluation for the adenoid’s bed to remove any remnant.
Hemostasis was secured by packing the operative bed
with a guaze soaked with 0.05% oxymetazoline. After

Recurrence
X-Ray Grade 2+ 3
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control of bleeding and pack removal, hemostasis was
achieved by dealing with any bleeding point by the
bipolar coagulator by retraction of the soft palate.
C.

Postoperative protocol: All patients were given the same
medical treatment in the form of:
1. Oral Amoxicillin-clavulanic acid for 10 days. Oral
macrolides were used in cases of amoxicillin allergy.
2. Oral Acetamenophin for 5 days.
3. Local nasal decongestant; Xylometazoline 0.5 mg/
ml for 5 days.
In the above mentioned drugs, the doses were calculated
according to the body weight of the patient. Both groups
were followed up 2weeks & 6 months postoperatively.
Recurrence of hypertrophied adenoid was evaluated by
Clinical manifestations:
nasal obstruction, nasal discharge, snoring, nasal tone of
voice and recurrent infection and scored according to given
questionnaire.
Radiological assessment:
Signs By The Lateral View Nasopharyngeal Radiograph, plain
x-ray nasopharynx with soft tissue radiation dose with mouth
opened and neck extended was done for all patients to detect
adenoid recurrence. The size of the adenoids was graded
according to the palatal airway measured from the most
convex point of the adenoid tissue to the soft palate. The
narrowest distance between the nasopharyngeal soft tissue
and the soft palate was taken. Grading was as follows, Grade
1: >6 mm; Grade 2: 3–6 mm; Grade 3: 0–3 mm. Grades 2
and 3 were considered recurrent obstructive adenoid [30].
The lateral radiographs were done before surgery and 6
months postoperatively
Statistical analysis:
Pre-coded data was entered on the computer using “Microsoft
Office Excel Software” program (2016) for windows. Data was
then transferred to the Statistical Package of Social Science
Software program, version 24 (SPSS) to be statistically
analyzed. Data was summarized using mean, standard
deviation, median, minimum and maximum in quantitative
data and using frequency (count) and relative frequency
(percentage) for categorical data. Comparisons between
quantitative variables were done using the non-parametric
Mann-Whitney test (Chan, 2003a). For comparing categorical
data, Chi square (X2) test was performed. Exact test was
used instead when the expected frequency is less than 5
(Chan, 2003b).
P values less than 0.05 were considered statistically significant,
and less than 0.01 were considered highly significant.
Results
The present study included 60 children. Patients after
adenoidectomy were divided into 2 groups, with ages range
from 3 to 12 years for both groups.

Drug group (n=30)
Count

Drug group (n=30)
%

Placebo group (n=30)
Count

Placebo group (n=30)
%

P value

1

3.3%

7

23.3%

0.052*

Nasal Obstruction

3

10%

12

40%

0.007*

Nasal discharge

3

10%

12

40%

0.007*

Snoring

3

10%

12

40%

0.007*

Nasal Tone

2

6.7%

11

36.7%

0.005*

Recurrent Infection

3

10%

12

40%

0.007*
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Group I: which included 30 patients, received intranasal
steroid fluticasone furoate (27.5 mcg/day) at postoperative
week 2 after wound healing.
Group II: which included 30 patients, received intranasal
saline spray starting at postoperative week 2 after wound
healing. Both medications were administered for 8 weeks
postoperatively. Patients were followed up for 6 months.
Follow up was done using the nasopharyngeal lateral X-rays
and reporting the degree of the symptoms All patients or
parents were asked to report the degree of the symptom
after 2 weeks, 6 months.
*Significance level obtained (p<0.05).
Discussion
Revision adenoidectomy is common. However, a review of
the literature, including some prominent textbooks, does
not illuminate the issue or its frequency. Buchinsky and
coworkers failed to find a new obstructing adenoid pad
after adenoidectomy in a large series of children, [8] while,
on the contrary, Joshua and his colleagues found a new
obstructing adenoid tissue in the clinical practice. They
reported infrequent occurrence of adenoid re-growth after
adenoidectomy that causes nasal obstruction which accounts
for 3% of patients with persistent post adenoidectomy
symptoms. [4]
Adenoidectomy can reduce both nasal obstructions and
upper respiratory infections. However, some patients
display clinically significantly persistent nasal symptoms
even after surgery. Symptoms, such as nasal obstruction or
recurrent upper respiratory infections, persist in 19–26% of
patients. [4] Adenoidectomy remains a commonly performed
procedure, although it produces short-term benefits. [16]
In our study, postoperative intranasal steroid fluticasone
furoate was used starting postoperative week 2 after wound
healing and was administered for 8 weeks postoperatively.
Patients were followed up for 6 months using the
nasopharyngeal lateral X-rays and reporting the degree of
the symptoms. All patients or parents were asked to report
the degree of the symptom after 2 weeks, 6 months.
Demain and Goetz in 1995, Successfully introduced the
use of intranasal steroid treatment in children with adenoid
hypertrophy. It was also demonstrated that the medical
use of intranasal corticosteroids like Mometasone furoate
[17] or Fluticasone propionate [14] for the treatment of
adenoid hypertrophy achieved significant improvements in
symptoms. It was reported that treatment with intranasal
steroids can decrease the size of adenoid hypertrophy, using
beclomethasone, [18] fluticasone, [19] and mometasone.
[20]
Bitar and his colleague in 2016, found that among the
steroids used in the various reviewed trials, mometasone
is the most studied. However, none of the reviewed studies
investigated the long-term effect of this treatment. They
demonstrated a persistence of the improvement in 75 per
cent of the patients who continued to attend follow up, one
year after the cessation of treatment. This was the first longterm follow-up study on patients previously treated with
mometasone furoate monohydrate. [21]
The duration of treatment with intranasal steroids in previous
studies varied from 8 to 24 weeks. None of these trials
established the optimal duration of treatment in children.
Criscuoli and his colleague in 2003, showed in the study
they conducted that the effects became visible 2 weeks

after the start of the treatment. Twenty-four patients
exhibited improvement after 2 weeks of steroid treatment,
and an additional 24 weeks of therapy at a lower steroid
dose maintained clinical improvement at 52 and 100 weeks
for 45.8% of those patients. In our study treatment was
continued for 8 weeks following adenoidectomy. [22]
Bitar et al., 2016, showed that the short-term effect of
intranasal steroids on obstructive adenoids is encouraging,
especially given that this effect was observed using a variety
of steroids. The optimal treatment duration is not known. A
positive effect has been reported with a treatment duration
as short as four weeks, but others have given a treatment
time as long as seven months. [21]
Bitar et al., 2013, observed that no additional effect was
gained after six weeks of treatment with mometasone
furoate spray. [23]
Like our study Sobhy, 2013, performed the assessment
of adenoid size using lateral nasopharyngeal radiography
since pediatric patients were not able to tolerate flexible
nasopharyngoscopy well. Adenoid nasopharynx ratio (A/N)
is the most frequently used method for the assessment of
adenoid size on the lateral nasopharynx X-ray. [15]
Unlike our study in Yildirim et al., 2016, Every patient had
flexible nasal endoscopy at postoperative week 3 and one
year after the operation. Choana was scored according to
its occlusion level by the adenoid tissue. Additionally, nasal
obstruction symptoms (nasal congestion, dry mouth, snoring,
nasal speaking, apnea and night coughing) were scored. [24]
The literature review performed by M.F.N Feres et al., 2011,
in three studies did not find the A/N ratio to be correlated
with the adenoid size while two studies found them to be
correlated. X-ray has advantages such as being non-invasive
and easily administered, its disadvantages are that it offers
a two-dimensional view and is static. Furthermore, the effect
of radiation may not be ignored albeit at low doses. However,
the bigger problem is that the A/N ratio changes on the
lateral nasopharynx X-rays in the phases of respiration and
swallowing. For this reason, it should be purposefully taken
at the end of the inspiration. But it is quite difficult to take
X-rays at this particular time of respiration, especially during
pediatric ages. [25]
Computed tomography scan is not normally used to evaluate
the adenoids, the use of pediatric CT, which is a valuable
imaging tool, has been increasing rapidly. However, because
of the potential for increased radiation exposure to children
undergoing these scans, pediatric CT is a public health
concern. Thus, in our study we considered the cost-benefit
and radiation exposure risk of CT and we didn’t use CT
as a diagnostic tool for diagnosis or follow up for adenoid
hypertrophy.
In the current study, we could not perform endoscopy for
all children, although it is now the best diagnostic technique
for diagnosis of adenoid related nasal obstruction because it
depends on the age and compliance of the child.
Our study showed that the use of intrnasal steroids after
adenoidectomy was beneficial to prevent recurrence of
nasal symptoms and prevent recurrence of adenoid after
adenoidectomy after a follow-up period of 6 months.
Regarding X-ray nasopharynx grade as an evidence for
adenoid regrowth, there was statistically significant difference
between patients in the two group 6 months postoperative
with (P value 0.05) towards the drug group.
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Also, there was statistically significant difference between
patients in the two groups 6 months postoperative towards
the drug group regarding Nasal Obstruction, Nasal Discharge,
Snoring, Nasal Tone and recurrent infection with P value
(0.007,0.007,0.007,0.005,0.007) respectively.
It was also found that adenoid recurrence as evident by grade
2 and 3 in Lateral X-Ray Nasopharynx was numerically higher
in the age group 3-5 years but wasn’t clinically significant
(P value = 0.299).
Sobhy, 2013 was the first to compare the use of steroids and
saline nasal spray after adenoidectomy. This study identified
a significant improvement in the scores for nasal obstruction,
discharge and snoring with the use of postoperative nasal
corticosteroids. The assessment performed on the lateral
nasal X-ray found that it was effective in preventing adenoid
regrowth. [15]
These results were like Yildirim et al., 2016, In the flexible
endoscopic assessment completed in the twelfth month of
the study, significant reduction was found in drug group
compared to placebo in terms of adenoid size. When patients
in both groups were compared, statistically significant
reduction was observed in nasal obstruction symptom scores
at the twelfth month. [24]
Ciprandi and coworkers, 2007, found that the use of intranasal
flunisolide was associated with a significant reduction of
adenoid hypertrophy in 72.6 % of the children. On the
contrary, isotonic saline solution was associated with a nonsignificant improvement of adenoid hypertrophy as reported
in 30.7% of children [26]. Another study by Criscuoli et al.,
2003, provided evidence that treatment with nasal steroids
could represent for some children an effective means of
avoiding adenoidectomy. [22]
Lepcha and coworkers, 2002, did not find any significant
efficacy of intranasal steroids in improving nasal blockage,
nasal discharge, or snoring, although a fivefold reduction in
adenoid size was observed in intranasal steroid group when
compared with the placebo group. However, this difference
did not reach a statistical significance. [27]
Steroids are generally well tolerated in children. Studies
showed only one case of episodic nasal bleeding. [17] The
effect of intranasal steroids on growth was studied by Allen
and his colleagues in a randomized, double-blind, placebocontrolled study. [28] The growth rate in pre-puberty children
who had used intranasal steroids for 1 year was reported to
be equal to the growth rate of the placebo control group.
The mechanisms by which topical steroids improve nasal
airway obstructive symptoms remain unclear. Three main
trials succeeded to demonstrate the improvement of nasal
obstruction with reduction of adenoid size with the use
of intranasal steroids. [14,17,18] It may be due to the
lympholytic effect; the anti-inflammatory effect of steroids
help to reduce adenoidal and nasopharyngeal inflammation
or they reduce the possibility of the adenoid acting as an
infection reservoir. Studies which proved the fact that adenoid
tissue includes many glucocorticoid receptors and messenger
RNA strengthens these probable mechanisms. [29]
The study is limited by the absence of the nasal endoscopic
examination which is considered the best diagnostic
technique for the diagnosis of the adenoid related nasal
manifestations. We did not include nasal endoscopy because
of the noncompliance of the children. One of the limitations
is the noncompliance of the children to the intranasal steroids
which is observed mainly in the young children. Another
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limitation of the study is the method of adenoidectomy which
is limited to the adenoid curette, although other methods are
used, but the most feasible method of adenoidectomy was
the adenoid curette. A multicenter study with longer followup for 1 year period on the study patients should elicit a more
informative data and properly evaluate the long-term effect
of intranasal corticosteroids after adenoidectomy.
Conclusion
Following Adenoidectomy, the use of intranasal steroids
may obtain successful results in children to prevent adenoid
regrowth and recurrence of related nasal symptoms. The
most appropriate drug, the most efficient dose, and optimal
treatment duration need to be investigated and determined.
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